|
![]() |
|||
|
||||
OverviewHepatic Encephalopathy and Nitrogen Metabolism is an interdisciplinary symposium bringing together basic science and clinical applications. It contains up-to-date research findings at the highest scientific level. Full Product DetailsAuthor: D. Häussinger , G. Kirchels , F. SchlessPublisher: Springer-Verlag New York Inc. Imprint: Springer-Verlag New York Inc. Edition: 2006 ed. Dimensions: Width: 15.50cm , Height: 3.30cm , Length: 23.50cm Weight: 2.290kg ISBN: 9781402044557ISBN 10: 1402044550 Pages: 590 Publication Date: 10 May 2006 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsPhysiology and pathophysiology of astrocytes.- Water transport in the brain: basic concepts and astrocytic swelling.- Osmotic and Oxidative stress in hepatic encephalopathy.- NADPH oxidase is a major source of swelling-induced generation of reactive oxygen species in rat astrocytes.- Detoxification of hydrogen peroxide by astrocytes.- Glutamate release from astrocytes: impact on neuronal function.- Hepatic stellate cells and astrocytes: similarities and differences.- Localization and function of ATP-binding cassette C (ABCC/MRP) efflux pumps in human brain.- Glial mechanisms of axonal growth protection from ammonia.- Selenoprotein P: A link between liver and brain.- Pathogenesis of hepatic encephalopathy.- The peripheral benzodiazepine receptor and neurosteroids in the pathogenesis of hepatic encephalopathy and ammonia neurotoxicity.- Glutamatergic synaptic regulation deficit in liver failure: A review of molecular mechanisms.- Synaptic plasticity in animal models relevant for hepatic encephalopathy.- N-methyl-D-aspartate receptors in hyperammonaemia and hepatic encephalopathy.- Prehepatic portal hypertension and mitochondrial dysfunction in brain hippocampus.- Nuclear magnetic resonance studies in experimental animal models of hepatic encephalopathy.- The role of inflammation in hepatic encephalopathy.- Brain imaging in hepatic encephalopathy research.- Altered neural oscillations and synchronization: a pathophysiological hallmark of hepatic encephalopathy.- Neurotransmitter receptor alterations in hepatic encephalopathy.- Quantitative T1 and water content mapping in hepatic encephalopathy.- Central nervous system involvement in hepatitis C virus infection: what to measure?.- Localized magnetic resonance-correlated spectroscopy using two spectral dimensions: theoretical description and pilot investigation in hepatic encephalopathy.- New aspects of nitrogen metabolism.- Urea cycle disorders.- Pathophysiology of citrin deficiency.- Hepatic encephalopathy in organic acidurias: hyperammonaemia and energy failure.- Glutamine synthetase deficiency in the human.- Hepatic dysfunction and encephalopathy in inborn errors of metabolism.- Amino acids and mammalian target of rapamycin-dependent signalling.- Ceramide is a negative regulator of insulin action, nutrient uptake and protein synthesis in cultured rat skeletal muscle cells.- Ammonia transport in aquaporins: molecular mechanisms and clinical relevance.- Glutamine synthetase as a target of ?-catenin: new insights into hepatic heterogeneity.- Ammonia metabolism in liver cirrhosis.- Clinical assessment of hepatic encephalopathy.- Definition and assessment of low-grade hepatic encephalopathy.- Hepatic encephalopathy in acute liver failure.- Quality of life in chronic liver diseases and in hepatic encephalopathy.- Hyponatraemia: A risk factor of hepatic encephalopathy in cirrhosis.- Neuropsychological dysfunction in minimal hepatic encephalopathy: a review compared with own experience.- Computerized or paper-and-pencil psychometric tests for the assessment of hepatic encephalopathy?.- Neurophysiological basis of critical flicker frequency (CFF) analysis.- Critical assessment of the PHES test battery in patients with low-grade hepatic encephalopathy.- Treatment.- Evidence-based medicine and hepatic encephalopathy treatment.- Brain oedema in acute liver failure: mechanisms and therapeutic options.- Hepatic encephalopathy and artificial liver support systems.- Prometheus® — a new extracorporeal system for the treatment of liver failure.- Modulation of intestinal flora for the treatment ofhepatic encephalopathy in cirrhosis.- Prevention of hepatic encephalopathy after porto-systemic shunt.- Milestones in research on hepatic encephalopathy.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |